Cannula Market Growth, Demand, Segmentation, Trends, Industry Size, Share and Forecast till 2023

 As per Market Research Future (MRFR) analysis, the global cannula market held a valuation of USD 113 million in 2017. It is estimated to grow at a CAGR of 6.7% from 2017 to 2023 (forecast period).

Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6937 

Cannula is a bendable hollow tube with a retractable, sharp inner core. It is placed into a patient's vein or artery or other body cavities for the removal or delivery of fluids during surgery or medical examinations, such as infusion of medication or blood samples collection.

Cannula Market Dynamics

The demand for surgical procedures is increasing all over the world as surgery has become standard treatment for various health conditions. It is acknowledged that the growing number of surgical procedures is a significant driver of the cannula market. As per the Australian Institute of Health and Welfare, there were 10.6 million hospitalizations in 2015–16 and 1 in 4 hospitalizations involved surgery.

Numerous other factors such as increasing demand for cannulas for ocular surgeries, expanding healthcare infrastructure, and growing research & development activities related to healthcare, are also anticipated to fuel the growth of the market. As stated in the Indian Journal of Opthalmology in 2017, J-shaped cannula has shown good surgical results in cortex removal techniques.

However, stringent government regulations and a lack of qualified or trained physicians can hinder the growth of the market over the forecast period.

Cannula Market Segmentation

The global market for cannula has been segmented into product, material, application, and end-user.

Based on the product, the global market for cannula has been segmented into cardiac cannulas, nasal cannulas, vascular cannulas, dermatology cannulas, arthroscopy cannulas, and others.

By material, the global market for cannula has been segmented into plastic (PVC), silicone, and metal (stainless steel).

By application, the global market for cannula has been segmented into cardiovascular surgery, oxygen therapy, general surgery, cosmetic/plastic surgery, orthopaedic surgery, and others.

By the end-user, the global market for cannula has been segmented into hospitals, ambulatory surgical centers, and others. The hospital segment is expected to dominate market share due to an increase in hospitalizations and a significant number of hospital surgeries. Ambulatory surgical centers are expected to increase at the highest level of CAGR due to the increasing demand for modern healthcare facilities.

 

Region-wise, the global market for cannula has been segmented into the Americas, Europe, the Asia Pacific, and the Middle East & Africa

The Americas are expected to dominate the global cannula market due to increasing healthcare expenditure, expanding the number of surgeries, and improving healthcare infrastructure. According to Centers Medicare and Medicaid Services, National Health Care Expenditure increased from the previous year by 4.3% to USD 3.3 trillion in 2016.

Europe is set to retain the second-largest position on the global cannula market. Market growth in this area is due to government support and the advancement of research and development related to healthcare activities.

The Cannula Market in the Asia Pacific region comprises countries such as China, the Republic of Korea, Japan, India, Australia, and the rest of the Asia Pacific. The Asia Pacific region is anticipated to witness the fastest growing region owing to the massive demand for minimally invasive surgeries and increasing healthcare spending. According to the World Bank Group, India spent 3.89% of its Gross Domestic Product (GDP) on health.

The Middle East and Africa are predicted to have the least market share. Market growth in this area is anticipated to be driven by the development of healthcare infrastructure.

 

Cannula Market Key players

Some of the significant participants in the global cannula market are Medtronic, Edwards Lifesciences Corporation, Teleflex Incorporated, Terumo Cardiovascular Systems Corporation, LivaNova PLC, Smith & Nephew, Smiths Medical, Boston Scientific Corporation, CONMED Corporation, Harsoria Healthcare Pvt. Ltd., ISPG Inc., ILIFE MEDICAL DEVICES PRIVATE LIMITED (INDIA), McKesson Medical-Surgical Inc., Denex International, BD, and others.

 

Read Complete Report With Toc @ https://www.marketresearchfuture.com/reports/cannula-market-6937 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Anti-viral drugs Market Growth Is Driven By The Increasing Demands of Various Therapies and Geographical Regions

 Anti-viral Drugs Market Highlights 

The global anti-viral drugs market is likely to touch an impressive valuation of USD 62.67 billion by 2022, predicts Market Research Future (MRFR). The report published by MRFR on the global anti-viral drugs market mentions that the market is projected to register a CAGR of 6.9% between 2013 and 2022.

Download Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2454 



Anti-viral Drugs Market Key Players

MRFR have enlisted some of the prominent companies operating in the anti-viral drugs market. They are; Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co. Inc., Gilead Sciences Inc., Cipla Inc. GlaxoSmithKline Plc, Novartis International AG, Abbott Laboratories, and  Astra Zeneca AB.  

Anti-viral Drugs Market Synopsis

The rising cases of viral disease is identified to boost the global anti-viral drugs market growth. The inadequacy of dietary nutrition in people, due to increase in consumption of high calorie and low fibrous food is creating favourable condition for virus to invade human body. Hence, the need for anti-viral drugs are surging as viral infections prevail. The growing incidences of HIV and other sexually-transmitted diseases are also boosting the sales number of anti-viral drugs, hence, anticipated to prompt the anti-viral drug market growth.

The increase in cases of drug resistance is propelling extensive research and developmental undertakings for launching more effective anti-viral drugs. Additionally, the stringency in drug approval stages are taking care of the quality of drugs in the pipeline. New product launches are gaining traction for revenue generation for the anti-viral drugs market. The application of anti-viral drugs in other diseases like, bird flu, and others is also likely to prompt the global anti-viral drug growth. 

The expiry of patents for certain blockbuster anti-viral drug are stimulating generic drug competition in the anti-viral drug market. This is deepening the competitive scenario of the global anti-viral drug market over the assessment period. 

However, adverse effects of anti-viral drugs and high price of anti-viral drugs can hinder the anti-viral drugs market growth over the assessment period.  

Anti-viral Drugs Market Segmental Overview

The global anti-viral drugs market study has been segmented on the basis of application and mechanism of action.

Based on the application, the anti-viral drugs market has been segmented into Influenza, Hepatitis, Herpes, HIV/AIDS, and others. 

Based on the mechanism of action, the anti-viral drugs market has been segmented into Protease Inhibitors, Nucleotide Polymerase Inhibitors, Reverse Transcriptase Inhibitors, and others. 

Anti-viral Drugs Market Regional Outlook

Based on the region, the anti-viral drug market has been studied across the Americas, Asia Pacific, Europe, and the Middle East Asia.

MRFR forecasts that the anti-viral drug market in the American region is likely to hold the largest market share. The need for effective treatment of diseases due to the growing cases of viral infection in the region can bolster the anti-viral drugs market. The North American market is expected to grasp greater than 30% of the global market share. The anti-viral drugs market in Europe is likely to garner an impressive CAGR by 2022. MRFR report states that the anti-viral drugs market in Europe will hold the second largest market share over the review period. The anti-viral drug market in the Asia pacific region anticipated to register the highest CAGR over the forecast period. The anti-viral drug market in the Middle East Asia and Africa is expected to exhibit a sluggish growth. 

Browse Complete Report with Covid19 Impact @ https://www.marketresearchfuture.com/reports/anti-viral-drugs-market-2454 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Blog: https://healthcarenews12.blogspot.com/

 

Augmented Reality in Healthcare Market 2020 Global Size, Share, Technology Trends, Growth Opportunities, Top Company Analysis

Global Augmented Reality in Healthcare Market Report, Trends, Growth, Size and Industry Analysis by Component (Hardware, Software), Device Type (Head-Mounted Display), Application (Fitness Management) – Forecast till 2023

Augmented Reality in Healthcare Market Overview

MRFR has asserted that Augmented Reality in Healthcare Market growth is likely to achieve a valuation of USD 1.32 Bn at a dynamic CAGR of 23% by 2023.

The application of augmented reality in healthcare is still in its nascent stage but has shown signs of potentials to improve clinical outcomes. Market Research Future (MRFR) has thoroughly studied the trends and patterns governing the global augmented reality in the healthcare market over the forecast period of 2017-2023 in an extensive study. 

The application of augmented reality in healthcare has uncovered many new opportunities in the healthcare sector. Augmented reality in healthcare can assist doctors in diagnosing, treating, and performing surgeries with enhanced efficiency. The growth of the market stems from the increasing penetration of smart connected devices in the healthcare sector. Moreover, the rise in surgeries using laparoscopy, endoscopy, catheterized intervention has further paved d the way of the expansion of the market. The medical application of augmented reality is being vigorously studied by researchers which coupled with high investment from various governments is expected to propel the market. Advances in advances in camera and sensor technology and AR-focused software research is likely to expedite the growth of the market in the coming years. Other factors contributing to the market growth include high healthcare expenditure and application of augmented reality in medical training, pharmacy benefit management, and patient education. 

On the other hand, lack of proper infrastructure to incorporate augmented reality in healthcare, especially in developing countries is likely to hinder the growth of the market. Additionally, lack of technical know-how and reluctance among medical practitioners to adopt new technologies might constrain the growth of the market over the forecast period. Moreover, high costs associated with it, limited functionality, and perception problems are other bottlenecks to the growth of the market. 

Augmented Reality in Healthcare Market Segmentation

Global augmented reality in healthcare market has been segmented based on device type, component, and application.

By device, the augmented reality in healthcare market has been segmented into handheld device, head-mounted display, and others. 

By component, the augmented reality in healthcare market has been segmented into software, hardware, and others. 

By application, the augmented reality in healthcare market has been segmented into medical training, fitness management, and education, among others. 

Augmented Reality in Healthcare Market Regional Analysis

By region, the augmented reality in healthcare market has been segmented into North America, Asia Pacific (APAC), Europe, and Rest-of-the-World (RoW). 

North America is the largest augmented reality in healthcare market share. A robust healthcare infrastructure in the region supports the growth of the market. Moreover, the region is a frontrunner in the adoption of latest technologies due to which augmented reality has gained widespread acceptance among healthcare professionals. High healthcare expenditure and technological advances in the field has further supported the market growth. Moreover, the presence of various market players in the region favors market growth. 

Europe is an important revenue pocket for the augmented reality in healthcare market. Increasing healthcare expenditure along with changing healthcare policies is expected to foster the growth of the market. 

The APAC augmented reality in healthcare market report is likely to be driven by rapid technological adoption in the developing economies of the region. Moreover, fast track economic progress and improvements in healthcare infrastructure have the potential to trigger growth within the market. The APAC market is estimated to register the highest CAGR over the forecast period. 

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/augmented-reality-in-healthcare-market-5236

Augmented Reality in Healthcare Market Competitive Landscape

Osterhout Design Group (U.S.), Virtually Better (U.S.), DAQRI (U.S.), Blippar (U.K), VirtaMed (Switzerland), Wikitude GmbH (Austria), Microsoft Corporation (U.S.), CAE Healthcare (U.S.),

Google LLC. (U.S.), Augmedix (U.S.), Oculus VR (U.S.), Magic Leap, Inc. (U.S.), HTC (Taiwan),

Philips Healthcare (Netherlands & U.S.), 3D Systems (U.S.), Medical Realities (U.K), Mindmaze (Switzerland), Atheer (U.S.), Siemens Healthineers (Germany) are the distinguished companies in augmented reality in healthcare market.

Augmented Reality in Healthcare Industry Updates

March 2019 - Koninklijke Philips N.V., a Dutch company dedicated to creating the future of healthcare, and Microsoft Corporation, the global technology giant, have jointly developed an augmented reality concept for image-guided minimally invasive surgeries. The concept is based on Philips’ Azurion image-guided therapy platform and Microsoft’s HoloLens 2 holographic computing platform. 

Biosimilars Market Comprehensive Analysis, Trends, Growth and Demand

 Atrial Fibrillation Market Overview:

Rapid technological advancement is aiding the healthcare sector for the development of advanced medical devices to treat various complex health conditions. Atrial fibrillation is a medical condition where the heartbeats are irregular which increases the risk of stroke, heart failure, blood clots and other heart-related complications. This condition may sometime require surgical treatments such as ablation, pacemakers and others. Market Research Future (MRFR) has published a detailed report stating that the global atrial fibrillation market is marked to expand at a notable growth rate during the forecast period of 2017-2023.

 

Get request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6520 

 

Atrial Fibrillation Market Drivers and Restraints:

Increasing prevalence of atrial fibrillation owing to the factors such as high alcohol consumption, hypertension and other chronic diseases, changing lifestyle and rise in geriatric population are majorly fueling the growth of the global atrial fibrillation market. Rapid adoption of advanced technology in the healthcare sector in order to improve the diagnostic and treatment procedures and availability of high-resolution images that can be obtained for proper diagnosis of heart conditions are propelling the growth of the global atrial fibrillation market. Increased research and development in the healthcare sector in various regions is also driving the expansion of the global atrial fibrillation market. However, absence of primary healthcare services and low penetration of advanced technology in the underdeveloped countries are likely to restrain the expansion of the global atrial fibrillation market during the forecast period.

 

Atrial Fibrillation Market Segmentation:

The global atrial fibrillation market has been segmented on the basis of product and end-users. Based on product, the atrial fibrillation market has been segmented into non-surgical and surgical. Based on end-users, the global atrial fibrillation market has been segmented into cardio centers, big hospitals, and heart specialty care enterprises. The heart specialty care enterprises segment commands the major share in the global atrial fibrillation market.

 

Atrial Fibrillation Market Regional Analysis:

Geographically, the global atrial fibrillation market has been segmented into four major regions such as the Americas, Europe, Asia Pacific and the Middle East and Africa. The Americas project significant growth in the global atrial fibrillation market owing to the increasing prevalence of heart conditions as a result of changing lifestyle, busy work culture and unhealthy dietary habits of the population in this region. Easy adoption of technologically advanced treatment solutions in the well-developed healthcare sector is also propelling the growth of the atrial fibrillation market in this region. Increased research and development expenditure for introduction of advanced treatment and diagnosis techniques is fueling the growth of the atrial fibrillation market in the Europe region. Rise in prevalence of individuals suffering from atrial fibrillation and development of healthcare sector in the emerging economies are aiding the growth of the atrial fibrillation market in the Asia Pacific region. The Middle East and Africa region is anticipated to project sluggish growth in the global atrial fibrillation market owing to the lack of primary healthcare services and poor economic conditions in the underdeveloped areas of this region.

 

Industry Updates:

In November 2018, Johnson and Johnson Medical Devices Company has announced that Biosense Webster Inc. has successfully treated the first patient in its STELLAR U.S. Investigational Device Exemption (IDE) study that has been carried out to evaluate safety and effectiveness of Heliostar Multi-electrode Radiofrequency balloon ablation catheter in treating atrial fibrillation. 

 

In December 2018, it has been announced the first patient has been treated in the TERMINATE AF study for evaluation of Cardioblate Irrigated RF System of Medtronic and also its CryoFlex Surgical Ablation System for the patients with persistent atrial fibrillation that are undergoing open heart surgery. 

 

Key Players:

The prominent players profiled by MRFR that are operating in the global atrial fibrillation market are Biosense Webster, Carima, Agricore, Medtronic, and St. Jude Medical.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/atrial-fibrillation-systems-market-6520 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com 

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Atrial Fibrillation Market Growth 2021 | Worldwide Overview By Top Vendors, Demand, Technology Trends, Regional Outlook, Statistics Data and Forecast

 

Atrial Fibrillation Market Overview:

Rapid technological advancement is aiding the healthcare sector for the development of advanced medical devices to treat various complex health conditions. Atrial fibrillation is a medical condition where the heartbeats are irregular which increases the risk of stroke, heart failure, blood clots and other heart-related complications. This condition may sometime require surgical treatments such as ablation, pacemakers and others. Market Research Future (MRFR) has published a detailed report stating that the global atrial fibrillation market is marked to expand at a notable growth rate during the forecast period of 2017-2023.

Get request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6520 

Atrial Fibrillation Market Drivers and Restraints:

Increasing prevalence of atrial fibrillation owing to the factors such as high alcohol consumption, hypertension and other chronic diseases, changing lifestyle and rise in geriatric population are majorly fueling the growth of the global atrial fibrillation market. Rapid adoption of advanced technology in the healthcare sector in order to improve the diagnostic and treatment procedures and availability of high-resolution images that can be obtained for proper diagnosis of heart conditions are propelling the growth of the global atrial fibrillation market. Increased research and development in the healthcare sector in various regions is also driving the expansion of the global atrial fibrillation market. However, absence of primary healthcare services and low penetration of advanced technology in the underdeveloped countries are likely to restrain the expansion of the global atrial fibrillation market during the forecast period.

Atrial Fibrillation Market Segmentation:

The global atrial fibrillation market has been segmented on the basis of product and end-users. Based on product, the atrial fibrillation market has been segmented into non-surgical and surgical. Based on end-users, the global atrial fibrillation market has been segmented into cardio centers, big hospitals, and heart specialty care enterprises. The heart specialty care enterprises segment commands the major share in the global atrial fibrillation market.

Atrial Fibrillation Market Regional Analysis:

Geographically, the global atrial fibrillation market has been segmented into four major regions such as the Americas, Europe, Asia Pacific and the Middle East and Africa. The Americas project significant growth in the global atrial fibrillation market owing to the increasing prevalence of heart conditions as a result of changing lifestyle, busy work culture and unhealthy dietary habits of the population in this region. Easy adoption of technologically advanced treatment solutions in the well-developed healthcare sector is also propelling the growth of the atrial fibrillation market in this region. Increased research and development expenditure for introduction of advanced treatment and diagnosis techniques is fueling the growth of the atrial fibrillation market in the Europe region. Rise in prevalence of individuals suffering from atrial fibrillation and development of healthcare sector in the emerging economies are aiding the growth of the atrial fibrillation market in the Asia Pacific region. The Middle East and Africa region is anticipated to project sluggish growth in the global atrial fibrillation market owing to the lack of primary healthcare services and poor economic conditions in the underdeveloped areas of this region.

Industry Updates:

In November 2018, Johnson and Johnson Medical Devices Company has announced that Biosense Webster Inc. has successfully treated the first patient in its STELLAR U.S. Investigational Device Exemption (IDE) study that has been carried out to evaluate safety and effectiveness of Heliostar Multi-electrode Radiofrequency balloon ablation catheter in treating atrial fibrillation. 

In December 2018, it has been announced the first patient has been treated in the TERMINATE AF study for evaluation of Cardioblate Irrigated RF System of Medtronic and also its CryoFlex Surgical Ablation System for the patients with persistent atrial fibrillation that are undergoing open heart surgery. 

Key Players:

The prominent players profiled by MRFR that are operating in the global atrial fibrillation market are Biosense Webster, Carima, Agricore, Medtronic, and St. Jude Medical.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/atrial-fibrillation-systems-market-6520 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com 

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Analysis on Cardiac Monitoring and Cardiac Rhythm Management Devices Market Trends and Demand by Top Leaders

 Global Cardiac Monitoring and Cardiac Rhythm Management Device Market Overview

A cardiac monitoring device enables the observing of a patient’s cardiac activity. A cardiac rhythm management device maintains a normal cardiac rhythm in patients suffering from irregular heart rate and rhythm disorder. According to the analysis conducted and the latest report published by MRFR, the global cardiac monitoring and cardiac rhythm management device market are estimated to record a 4% CAGR during the forecast period. Many factors are leading the global market for cardiac monitoring and cardiac rhythm management devices through the review period.

Some of these factors include the increasing cardiac disorders, changing lifestyles, as well as, technological advancements in cardiac devices. Further, the rising awareness towards cardiac disorders and healthcare programs is contributing heavily to the unparalleled growth witnessed by the global cardiac monitoring and cardiac rhythm management device market. The increasing unmet medical needs in developing and underdeveloped economies have also led to the proliferating adoption of cardiac monitoring and cardiac rhythm management devices in different healthcare organizations and hospitals. The development of new MRI-labeled devices and the economic development in Asia Pacific are likely to drive the cardiac monitoring and cardiac rhythm management device market to a great extent. 

Further, increasing technical advancements observed in the drug-eluting, MRI compatible pacemakers, and Holter monitors are some other factors pushing the cardiac monitoring and cardiac rhythm management device market during the forecast period. Intensifying demand for minimally invasive surgeries is correspondingly witnessed to drive growth in the cardiac monitoring and cardiac rhythm management device market. However, some factors are posing as hindrances in the growth of the global cardiac monitoring and cardiac rhythm management device market. Some of the factors refraining the market from growing include stringent regulatory approval procedures, high cost of cardiac devices, and the lack of reimbursement policies in developing countries.

Market Segmentation

The global cardiac rhythm management and cardiac monitoring device market has been analyzed for various segments. Such segmentation has been carried out on the basis of type, end-users, and region. On the basis of type, the global cardiac monitoring and cardiac rhythm management device market has been segmented into cardiac devices, types of cardiac monitoring devices, and types of cardiac rhythm management devices. Further, the types of cardiac devices segment is further segmented into pacemaker, implantable cardioverter defibrillator, biventricular pacemaker, loop recorder, and implantable cardiac. 

The types of cardiac monitoring devices segment has been further sub-segmented into electrocardiogram (ECG), Holter monitor, implantable loop recorder, event monitor, and cardiac output monitoring devices. The Electrocardiogram segment is further sub-segmented into telelectro-cardiogram, lead ECG test, and wireless ECG. 

The segment for cardiac rhythm management devices has been sub-segmented into defibrillators, cardiac resynchronization, therapy devices, and pacemakers. The defibrillators segment is further sub-segmented into implantable defibrillators and external defibrillators. Based on end-users, the global cardiac monitoring and cardiac rhythm management device market is segmented into ambulatory surgeries and hospitals.

Detailed Regional Analysis

The global cardiac monitoring and cardiac rhythm management device market has been studied for the regional segments of the Americas, Europe, Asia Pacific, and the Middle East & Africa. North America is likely to govern the global cardiac monitoring and cardiac rhythm management device market during the forecast period. Increasing investments by North America in cardiac devices in the last few years has contributed heavily to the ascension of the market in the region. A rising number of cardiac patients, better healthcare infrastructure, and advanced cardiac monitoring technology are also estimated to drive the market to a great extent. 

Asia Pacific is expected to garner fastest market growth during the assessment period due to the swelling prevalence of cardiac diseases, mounting investments in healthcare, increasing geriatric population, and the expansion of market players in the region. Asia Pacific is likely to create new growth avenues for cardiac monitoring and cardiac rhythm management device market owing to the production of cost-effective products that are highly demanded in local and global markets.  

Key Players

Some of the prominent players in the cardiac monitoring and cardiac rhythm management device market include Abiomed, Brotionik SE and Co. KG, Berlin Hearth, Cardiac Science Corporation, Boston Scientific Corporation, General Electric(GE), Jarvik Hearth. Inc, Koninklijke Philips N.V, Hill Rom Services Inc, LivaNova plc, Nihon Kohden Corporation, ReliantHeart Inc, Medtronic plc, Schiller, and Abbott.

Industry Update

May 2019: Abbott announced the launch of their latest, smarter heart monitor for better arrhythmia detection. The next-generation Confirm Rx insertable cardiac monitor (ICM) is a paper-sized implantable device that combines smartphone connectivity and can be monitored remotely to track unpredictable hearth rhythm problems.  

Read more @  https://www.marketresearchfuture.com/reports/cardiac-monitoring-advance-technologies-global-market-6332  

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Blog: https://healthcarenews12.blogspot.com/

Near Infrared Imaging Market Driven by the Growing Use of Electronic Devices to Fuel Demand & to witness a Surge in Demand due to COVID-19

 Near Infrared Imaging Market Overview

Near infrared imaging can be defined as a type of non-invasive imaging technique, which uses the near-infrared radiations and is used to probe the oxygenation and concentration of hemoglobin in the muscle, brain, and other tissues. This procedure is also used to identify changes, which is caused by brain injury, activity, or disease. It also finds application in diagnosing Alzheimer’s disease, breast cancer, schizophrenia, and depression. As this technique provides improved resolution for differentiation of soft tissues from tumors and less harmful, it is advantageous over other imaging procedures. The global near infrared imaging market, as per a report by Market Research Future (MRFR) is touted to register a CAGR of 12.6% during the forecast period (2018–2023).

Latest Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/7424 

Rising geriatric population is considered one of the prime factors propelling the near infrared imaging market growth worldwide. Thus, reconstructive procedures will elevate the scope of the market in the long run. The surging number of bone grafting, skin grafting, and transplant are likely to provide impetus to the market. Moreover, low risk of radiation from infrared imaging will push the market to grow substantially. The increasing number of surgical procedures is expected to boost the demand for near infrared imaging. The rising occurrence of cancer will promote the market growth in the next couple of years.

On the contrary, the dearth of skilled professionals in order to operate the machines is estimated to deter the market growth in the foreseeable future.

Global Near Infrared Imaging Market: Segmental Analysis

The near infrared imaging market has been segmented on the basis of type, sample type, and end user.

By type, the market constitutes of automated devices and manual devices.

The sample type comprises plasma, blood, whole blood & red blood cells, stem cells, embryos, platelets, semen, ovum, and others.

The end users comprise hospitals & diagnostic laboratories, blood banks & transfusion centers, biotechnology & pharmaceutical companies, research & academic institutes, and others. Of these, the hospitals & diagnostic laboratories are anticipated to garner the major share owing to the rising cases of cancer and surging number of reconstructive and plastic surgeries performed in hospitals & diagnostic laboratories. 

Near Infrared Imaging Market Regional Frontiers

Geographically, the near infrared imaging market spans across Europe, the Americas, Asia Pacific, and the Middle East & Africa.

Considering the global scenario, the Americas is predicted to command the largest share and retain its dominance in the coming years, mainly due to the high domestic income of the population in the region. The existence of key market players is considered to be a major factor in encouraging the regional market’s growth. In this region, North America is considered to be the major revenue-generating region and the growth is majorly driven by the increasing healthcare spending, surging geriatric population, and soaring number of cosmetic surgeries. Moreover, the rapid adoption of advanced imaging systems and surging cases of target diseases will favor the regional market growth.

Europe has managed to seize the second-largest share globally, and the market’s growth can be credited to the existence of strong research and academic base, coupled with the availability of funding for research in the countries of Europe. The European Research Council, for instance, offer grants for scientific and technological research, which is conducted within the EU.

Meanwhile, the Asia Pacific is expected to expand at the fastest rate due to the rising government focus on biotechnology and biomedical sector. Also, the rising number of the target population in the region has promoted the market growth. The presence of huge patient population and increasing healthcare expenditure are likely to encourage the market growth in the coming years. Moreover, the constantly evolving life science sector, especially in economies like China, India, Malaysia, and others are expected to promote the regional market growth.

Industry Updates

September 2019: A team of researchers from MIT, Harvard, and other nearby hospitals has come up with an objective method of measuring the pain that an individual experience using a non-invasive imaging procedure. The technology measures the amount of oxygenated hemoglobin that indicates the underlying neural activity. Sensor is placed on the forehead in order to record the activity.

Competitive Dashboard

The top players operating in the near infrared imaging market include Li-Cor, Inc. (US), PerkinElmer, Inc. (US), Karl Storz Se & Co. Kg (Germany), Stryker Corporation (US), Leica Microsystems (Germany), Carl Zeiss Meditec AG (Germany), Hamamatsu Photonics K.K., (Japan), Medtronic (Ireland), Shimadzu Corporation (Japan), Olympus Corporation (Japan), Mizuho Medical Co., Ltd. (Japan), Quest Medical Imaging B.V. (the Netherlands), and others.

Browse Complete report with Toc @ https://www.marketresearchfuture.com/reports/near-infrared-imaging-market-7424 

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:                                

Akash Anand                                                                    

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com